In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia
Edwin Klumper, Gert J. Ossenkoppele, Rob Pieters, Dieuwke R. Huismans, Annemarie H. Loonen, Antoinette Rottier, Guus Westra, Anjo J.P. Veerman
Research output: Contribution to journal › Article › peer-review
44Citations
(Scopus)
Fingerprint
Dive into the research topics of 'In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia'. Together they form a unique fingerprint.